West Pharmaceutical Services Inc
WST272.440USD
+3.780+1.41%
Fechamento 12/19, 16:00（ET）Cotações atrasadas em 15 min
19.59BValor de mercado
40.12P/L TTM
Mais detalhes de West Pharmaceutical Services Inc Empresa
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Informações de West Pharmaceutical Services Inc
Código da empresaWST
Nome da EmpresaWest Pharmaceutical Services Inc
Data de listagemSep 01, 2059
CEOGreen (Eric Mark)
Número de funcionários10600
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 01
Endereço530 Herman O. West Drive
CidadeEXTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19341
Telefone16105942900
Sitehttps://www.westpharma.com/
Código da empresaWST
Data de listagemSep 01, 2059
CEOGreen (Eric Mark)
Executivos da empresa West Pharmaceutical Services Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+11.41%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+34.90%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+98.08%
Ms. Janet Brutschea Haugen
Ms. Janet Brutschea Haugen
Independent Director
Independent Director
1.56K
+216.80%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%
Por RegiãoUSD
Nome
Receita
Proporção
Europe Middle East and Africa
352.59M
46.00%
Americas
344.93M
45.00%
Asia Pacific
68.98M
9.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%
Distribuição de ações
Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Outro
69.50%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Outro
69.50%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.04%
Investment Advisor/Hedge Fund
32.14%
Hedge Fund
6.92%
Pension Fund
4.01%
Research Firm
2.24%
Bank and Trust
1.82%
Sovereign Wealth Fund
1.37%
Insurance Company
0.76%
Endowment Fund
0.62%
Outro
2.09%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
1640
70.77M
98.37%
-2.34M
2025Q2
1636
72.03M
100.16%
-1.82M
2025Q1
1662
71.25M
99.16%
-2.66M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
9.28M
12.91%
+83.24K
+0.90%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
5.27%
-358.56K
-8.65%
Jun 30, 2025
State Street Investment Management (US)
3.27M
4.55%
+68.33K
+2.13%
Jun 30, 2025
Artisan Partners Limited Partnership
2.27M
3.15%
+71.84K
+3.27%
Jun 30, 2025
Brown Advisory
3.02M
4.2%
-247.19K
-7.56%
Jun 30, 2025
Walter Scott & Partners Ltd.
2.20M
3.06%
-142.10K
-6.07%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.83M
2.55%
-20.69K
-1.12%
Jun 30, 2025
Van Eck Associates Corporation
1.49M
2.07%
+38.34K
+2.65%
Jun 30, 2025
APG Asset Management N.V.
1.66M
2.31%
+96.53K
+6.18%
Jun 30, 2025
Durable Capital Partners LP
1.04M
1.45%
-532.47K
-33.85%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Motley Fool Mid-Cap Growth ETF
3.52%
VanEck Morningstar Wide Moat ETF
2.83%
First Trust Indxx Medical Devices ETF
2.15%
VanEck Morningstar Wide Moat Value ETF
2.14%
Invesco S&P 500 Equal Weight Health Care ETF
1.8%
Nuveen ESG Mid-Cap Growth ETF
1.72%
American Century Mid Cap Growth Impact ETF
1.63%
Hilton Small-MidCap Opportunity ETF
1.51%
iShares Health Innovation Active ETF
1.5%
ProShares S&P 500 Dividend Aristocrats ETF
1.46%
Ver Mais
Motley Fool Mid-Cap Growth ETF
Proporção3.52%
VanEck Morningstar Wide Moat ETF
Proporção2.83%
First Trust Indxx Medical Devices ETF
Proporção2.15%
VanEck Morningstar Wide Moat Value ETF
Proporção2.14%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.8%
Nuveen ESG Mid-Cap Growth ETF
Proporção1.72%
American Century Mid Cap Growth Impact ETF
Proporção1.63%
Hilton Small-MidCap Opportunity ETF
Proporção1.51%
iShares Health Innovation Active ETF
Proporção1.5%
ProShares S&P 500 Dividend Aristocrats ETF
Proporção1.46%
Dividendo
Um total de
269.40M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 24, 2025
WST.NB Final Cash Dividend of gross USD 0.22 paid on Nov 19, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 19, 2025
Nov 12, 2025
Apr 24, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Aug 06, 2025 going ex on Jul 30, 2025
Jul 30, 2025
Aug 06, 2025
Jul 30, 2025
Feb 20, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on May 07, 2025 going ex on Apr 30, 2025
Apr 30, 2025
May 07, 2025
Apr 30, 2025
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de West Pharmaceutical Services Inc?
Os cinco principais acionistas de West Pharmaceutical Services Inc são:
The Vanguard Group, Inc. detém 9.28M Ações, representando 12.91% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 3.79M Ações, representando 5.27% do total de Ações.
State Street Investment Management (US) detém 3.27M Ações, representando 4.55% do total de Ações.
Artisan Partners Limited Partnership detém 2.27M Ações, representando 3.15% do total de Ações.
Brown Advisory detém 3.02M Ações, representando 4.20% do total de Ações.
The Vanguard Group, Inc. detém 9.28M Ações, representando 12.91% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 3.79M Ações, representando 5.27% do total de Ações.
State Street Investment Management (US) detém 3.27M Ações, representando 4.55% do total de Ações.
Artisan Partners Limited Partnership detém 2.27M Ações, representando 3.15% do total de Ações.
Brown Advisory detém 3.02M Ações, representando 4.20% do total de Ações.
Quais são os três principais tipos de acionistas de West Pharmaceutical Services Inc?
Os três principais tipos de acionistas da West Pharmaceutical Services Inc são:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Quantas instituições possuem ações da West Pharmaceutical Services Inc (WST)?
Em 2025Q3, 1640 instituições possuíam ações da West Pharmaceutical Services Inc, com valor de mercado aproximado de 70.77M, representando 98.37% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em -1.79%.
Qual é a maior fonte de receita da West Pharmaceutical Services Inc?
Em FY2025Q2, o segmento de negócios High Value Components gerou a maior receita para West Pharmaceutical Services Inc, totalizando 360.25M e representando 47.00% da receita total.
